Evaluating the potential of hERG channel agonists as mechanistically targeted antiarrhythmics

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Abnormal heart rhythms cause ~10 % of deaths in the western world and this number is increasing. To date there has been little success in identifying drugs that are effective in treating these disorders. By studying a rhythm disturbance called long QT syndrome we will examine whether specifically targeting drugs to the molecular building blocks of these arrhythmias is an appropriate route for development of more effective drugs.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $414,786.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

arrhythmia | cardiac arrhythmia | drug development | drug safety | electrophysiology | ion channels | modelling | sudden cardiac death